Interest Expense in USD of Vitro Biopharma, Inc. from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Vitro Biopharma, Inc. quarterly/annual Interest Expense history and change rate from Q2 2010 to Q1 2024.
  • Vitro Biopharma, Inc. Interest Expense for the quarter ending 30 Apr 2024 was $2.16M, a 3694% increase year-over-year.
  • Vitro Biopharma, Inc. Interest Expense for the twelve months ending 30 Apr 2024 was $2.51M, a 1345% increase year-over-year.
  • Vitro Biopharma, Inc. annual Interest Expense for 2023 was $270K, a 36.1% increase from 2022.
  • Vitro Biopharma, Inc. annual Interest Expense for 2022 was $198K.
  • Vitro Biopharma, Inc. annual Interest Expense for 2015 was $87.7K, a 16.2% increase from 2014.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.51M $2.16M +$2.1M +3694% 01 Feb 2024 30 Apr 2024 10-Q 31 May 2024
Q4 2023 $402K $172K +$132K +332% 01 Nov 2023 31 Jan 2024 10-Q 14 Mar 2024
Q3 2023 $270K $91.6K +$52.8K +136% 01 Aug 2023 31 Oct 2023 10-K 29 Jan 2024
Q2 2023 $217K $82K +$44K +116% 01 May 2023 31 Jul 2023 10-Q 28 Aug 2023
Q1 2023 $173K $56.9K +$9.97K +21.2% 01 Feb 2023 30 Apr 2023 10-Q 31 May 2024
Q4 2022 $163K $39.7K -$35K -46.9% 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024
Q3 2022 $198K $38.8K 01 Aug 2022 31 Oct 2022 10-K 29 Jan 2024
Q2 2022 $38K 01 May 2022 31 Jul 2022 10-Q 28 Aug 2023
Q1 2022 $47K 01 Feb 2022 30 Apr 2022 10-Q 13 Jun 2023
Q4 2021 $74.7K 01 Nov 2021 31 Jan 2022 10-Q 14 Mar 2023
Q1 2015 $69.7K -$21.7K -$2.87K -15.2% 01 Feb 2015 30 Apr 2015 10-Q 22 Jan 2016
Q4 2014 $72.5K -$20.6K -$2.95K -16.7% 01 Nov 2014 31 Jan 2015 10-Q 24 Mar 2015
Q3 2014 $75.5K $131K 01 Aug 2014 31 Oct 2014 10-K 22 Sep 2016
Q2 2014 -$19.1K -$3.71K -24.2% 01 May 2014 31 Jul 2014 10-Q 22 Sep 2014
Q1 2014 -$18.8K -$33.6K -228% 01 Feb 2014 30 Apr 2014 10-Q 22 Jan 2016
Q4 2013 -$17.7K 01 Nov 2013 31 Jan 2014 10-Q 24 Mar 2015
Q2 2013 -$15.4K -$28K -222% 01 May 2013 31 Jul 2013 10-Q 22 Sep 2014
Q1 2013 $14.8K +$26.7K 01 Feb 2013 30 Apr 2013 10-Q 19 Jun 2014
Q3 2012 $48.5K $58.4K +$88.2K 01 Aug 2012 31 Oct 2012 10-K 12 Feb 2014
Q2 2012 -$39.7K $12.6K +$2.7K +27.2% 01 May 2012 31 Jul 2012 10-Q/A 17 Oct 2012
Q1 2012 -$42.4K -$12K -$1.56K -15% 01 Feb 2012 30 Apr 2012 10-Q/A 22 Jun 2012
Q4 2011 -$40.8K -$10.6K +$2.00 +0.02% 01 Nov 2011 31 Jan 2012 10-Q 21 Mar 2012
Q3 2011 -$40.9K -$29.8K 01 Aug 2011 31 Oct 2011 10-K/A 16 Feb 2012
Q2 2011 $9.93K +$20.3K 01 May 2011 31 Jul 2011 10-Q/A 17 Oct 2012
Q1 2011 -$10.4K 01 Feb 2011 30 Apr 2011 10-Q/A 22 Jun 2012
Q4 2010 -$10.6K 01 Nov 2010 31 Jan 2011 10-Q 21 Mar 2012
Q2 2010 -$10.4K 01 May 2010 31 Jul 2010 10-Q/A 12 Oct 2011

Vitro Biopharma, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $270K +$71.7K +36.1% 01 Nov 2022 31 Oct 2023 10-K 29 Jan 2024
2022 $198K 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024
2015 $87.7K +$12.2K +16.2% 01 Nov 2014 31 Oct 2015 10-K 22 Sep 2016
2014 $75.5K +$135K 01 Nov 2013 31 Oct 2014 10-K 22 Sep 2016
2013 -$59.9K -$108K -223% 01 Nov 2012 31 Oct 2013 10-K 13 Feb 2015
2012 $48.5K +$89.4K 01 Nov 2011 31 Oct 2012 10-K 12 Feb 2014
2011 -$40.9K +$758 +1.82% 01 Nov 2010 31 Oct 2011 10-K/A 16 Feb 2012
2010 -$41.6K 01 Nov 2009 31 Oct 2010 10-K/A 16 Feb 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.